מדינה: ארצות הברית
שפה: אנגלית
מקור: NLM (National Library of Medicine)
SILVER (UNII: 3M4G523W1G) (SILVER - UNII:3M4G523W1G)
Uriel Pharmacy Inc.
ORAL
OTC DRUG
Directions: FOR ORAL USE. Use: Temporary relief of headache.
unapproved homeopathic
ARGENTUM 30 SPECIAL ORDER- ARGENTUM 30 SPECIAL ORDER LIQUID URIEL PHARMACY INC. _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- ARGENTUM 30 SPECIAL ORDER Directions: FOR ORAL USE. Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow. Active Ingredient: Argentum met. 30X Inactive Ingredients: Water, Salt Use: Temporary relief of headache. KEEP OUT OF REACH OF CHILDREN. Warnings: Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Questions? Call 866.642.2858 Made by Uriel, East Troy, WI 53120 www.urielpharmacy.com ARGENTUM 30 SPECIAL ORDER argentum 30 special order liquid PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:48 9 51-10 8 2 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH SILVER (UNII: 3M4G523W1G) (SILVER - UNII:3M4G523W1G) SILVER 30 [hp_X] in 1 mL INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH Uriel Pharmacy Inc. INGREDIENT NAME STRE NG TH WATER (UNII: 0 59 QF0 KO0 R) SO DIUM CHLO RIDE (UNII: 451W47IQ8 X) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:48 9 51-10 8 2-1 10 in 1 BOX 1 1 mL in 1 AMPULE MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved ho meo pathic 0 9 /0 1/20 0 9 LABELER - Uriel Pharmacy Inc. (043471163) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS Uriel Pharmacy Inc. 0 4347116 3 ma nufa c ture (48 9 51-10 8 2) Revised: 11/2014 קרא את המסמך השלם